Barbara Giabbai

Barbara Giabbai

Auto-generated profile, based on publicly available information

Barbara Giabbai

Biocrystallography Unit and Mass Spectrometry Unit, DIBIT San Raffaele Scientific Institute, via Olgettina 58, 20132 Milan, Italy

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ECElena Campaner
Elena Campaner
ARAlessandra Rustighi
Alessandra Rustighi
AZAlessandro Zannini
Alessandro Zannini
ACAlberto Cristiani
Alberto Cristiani
SPSilvano Piazza
Silvano Piazza
GSGiannino Del Sal
Giannino Del Sal
The prolyl isomerase PIN1, a critical modifier of multiple signalling pathways, is overexpressed in the majority of cancers and its activity strongly contributes to tumour initiation and progression. Inactivation of PIN1 function conversely curbs tumour growth and cancer stem cell expansion, restores chemosensitivity and blocks metastatic spread, thus providing the rationale for a therapeutic strategy based on PIN1 inhibition. Notwithstanding, potent PIN1 inhibitors are still missing from the arsenal of anti-cancer drugs. By a mechanism-based screening, we have identified a novel covalent PIN1 inhibitor, KPT-6566, able to selectively inhibit PIN1 and target it for degradation. We demonstrate that KPT-6566 covalently binds to the catalytic site of PIN1. This interaction results in the release of a quinone-mimicking drug that generates reactive oxygen species and DNA damage, inducing cell death specifically in cancer cells. Accordingly, KPT-6566 treatment impairs PIN1-dependent cancer phenotypes in vitro and growth of lung metastasis in vivo.

15 July 2005 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
BGBarbara Giabbai
Barbara Giabbai
SSStèpHane Sidobre
StèpHane Sidobre
MCMax Crispin
Max Crispin
YSYovan Sanchez-Ruìz
Yovan Sanchez-Ruìz
ABAngela Bachi
Angela Bachi
MDMassimo Degano
Massimo Degano
NKT cells are immunoregulatory lymphocytes whose activation is triggered by the recognition of lipid Ags in the context of the CD1d molecules by the TCR. In this study we present the crystal structure to 2.8 Å of mouse CD1d bound to phosphatidylcholine. The interactions between the ligand acyl chains and the CD1d molecule define the structural and chemical requirements for the binding of lipid Ags to CD1d. The orientation of the polar headgroup toward the C terminus of the α1 helix provides a rationale for the structural basis for the observed Vα chain bias in invariant NKT cells. The contribution of the ligand to the protein surface suggests a likely mode of recognition of lipid Ags by the NKT cell TCR.

1 January 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
LTLinda Tomasinsig
Linda Tomasinsig
BSBarbara Skerlavaj
Barbara Skerlavaj
NPNiv Papo
Niv Papo
BGBarbara Giabbai
Barbara Giabbai
YSYechiel Shai
Yechiel Shai
MZMargherita Zanetti
Margherita Zanetti
Mammalian antimicrobial peptides provide rapid defense against infection by inactivating pathogens and by influencing the functions of cells involved in defense responses. Although the direct antibacterial properties of these peptides have been widely characterized, their multiple effects on host cells are only beginning to surface. Here we investigated the mechanistic and functional aspects of the interaction of the proline-rich antimicrobial peptide Bac7(1-35) with mammalian cells, as compared with a truncated analog, Bac7(5-35), lacking four critical N-terminal residues (RRIR) of the Bac7(1-35) sequence. By using confocal microscopy and flow cytometry, we showed that although the truncated analog Bac7(5-35) remains on the cell surface, Bac7(1-35) is rapidly taken up into 3T3 and U937 cells through a nontoxic energy- and temperature-dependent process. Cell biology-based assays using selective endocytosis inhibitors and spectroscopic and surface plasmon resonance studies of the interaction of Bac7(1-35) with phosphatidylcholine/cholesterol model membranes collectively suggest the concurrent contribution of macropinocytosis and direct membrane translocation. Structural studies with model membranes indicated that membrane-bound Bac7(5-35) is significantly more aggregated than Bac7(1-35) due to the absence of the N-terminal cationic cluster, thus providing an explanation for hampered cellular internalization of the truncated form. Further investigations aimed to reveal functional implications of intracellular uptake of Bac7(1-35) demonstrated that it correlates with enhanced S phase entry of 3T3 cells, indicating a novel function for this proline-rich peptide.

25 March 2008 in Biochemistry
Verified
Journal Article
Closed access
EIElena Iovane
Elena Iovane
BGBarbara Giabbai
Barbara Giabbai
LMLaura Muzzolini
Laura Muzzolini
VMVittoria Matafora
Vittoria Matafora
AFArianna Fornili
Arianna Fornili
MDMassimo Degano
Massimo Degano

16 December 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SDStefania Demuro
Stefania Demuro
CSConall Sauvey
Conall Sauvey
STShailesh K. Tripathi
Shailesh K. Tripathi
RMRita Maria Concetta Di Martino
Rita Maria Concetta Di Martino
DSDa Shi
Da Shi
ACAndrea Cavalli
Andrea Cavalli

1 December 2018 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Open access
SRSamanta Raboni
Samanta Raboni
SRSvetlana Revtovich
Svetlana Revtovich
NDNicola Demitri
Nicola Demitri
BGBarbara Giabbai
Barbara Giabbai
Paola StoriciPaola Storici
Paola Storici
Andrea MozzarelliAndrea Mozzarelli
Andrea Mozzarelli
Methionine deprivation of cancer cells, which are deficient in methionine biosynthesis, has been envisioned as a therapeutic strategy to reduce cancer cell viability. Methionine γ-lyase (MGL), an enzyme that degrades methionine, has been exploited to selectively remove the amino acid from cancer cell environment. In order to increase MGL catalytic activity, we performed sequence and structure conservation analysis of MGLs from various microorganisms. Whereas most of the residues in the active site and at the dimer interface were found to be conserved, residues located in the C-terminal flexible loop, forming a wall of the active site entry channel, were found to be variable. Therefore, we carried out site-saturation mutagenesis at four independent positions of the C-terminal flexible loop, P357, V358, P360 and A366 of MGL from Citrobacter freundii, generating libraries that were screened for activity. Among the active variants, V358Y exhibits a 1.9-fold increase in the catalytic rate and a 3-fold increase in KM, resulting in a catalytic efficiency similar to wild type MGL. V358Y cytotoxic activity was assessed towards a panel of cancer and nonmalignant cell lines and found to exhibit IC50 lower than the wild type. The comparison of the 3D-structure of V358Y MGL with other MGL available structures indicates that the C-terminal loop is either in an open or closed conformation that does not depend on the amino acid at position 358. Nevertheless, mutations at this position allosterically affects catalysis.